Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
2.165
-0.055 (-2.48%)
Nov 21, 2024, 12:19 PM EST - Market open

Tenaya Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Selling, General & Admin
31.8233.1631.0818.417.814.56
Research & Development
90.9298.0494.5454.3931.123.15
Operating Expenses
122.74131.19125.6272.8138.9127.71
Operating Income
-122.74-131.19-125.62-72.81-38.91-27.71
Interest & Investment Income
5.47.061.950.110.090.45
Other Non Operating Income (Expenses)
0.120.050-0.020.391.03
EBT Excluding Unusual Items
-117.23-124.08-123.67-72.72-38.44-26.23
Gain (Loss) on Sale of Assets
-----0.03-0.01
Other Unusual Items
----0.080.01
Pretax Income
-117.23-124.08-123.67-72.72-38.4-26.23
Net Income
-117.23-124.08-123.67-72.72-38.4-26.23
Net Income to Common
-117.23-124.08-123.67-72.72-38.4-26.23
Shares Outstanding (Basic)
8274451811
Shares Outstanding (Diluted)
8274451811
Shares Change (YoY)
18.54%64.61%152.75%1724.33%28.62%-
EPS (Basic)
-1.43-1.68-2.76-4.10-39.50-34.71
EPS (Diluted)
-1.44-1.68-2.76-4.10-39.50-34.71
Free Cash Flow
-95.25-103.31-125.05-85.93-45.21-27.02
Free Cash Flow Per Share
-1.16-1.40-2.79-4.85-46.51-35.75
EBITDA
-114.18-122.51-119.15-69.85-36.43-25.72
D&A For EBITDA
8.568.696.472.962.481.99
EBIT
-122.74-131.19-125.62-72.81-38.91-27.71
Source: S&P Capital IQ. Standard template. Financial Sources.